![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessP16INK4A expression might be associated with a favorable prognosis for cervical adenocarcinoma via dysregulation of the RB pathway
Previous studies have largely failed to clarify the relationship between p16INK4A status and cervical adenocarcinoma prognosis. The current study aimed to examine the clinical and pathological significance of p16
-
Article
Open AccessNeutropenic enterocolitis-induced sepsis and disseminated intravascular coagulation after chemotherapy: a case report
Neutropenic enterocolitis (NE) is a potentially life-threatening disease that primarily occurs in cancer patients treated with chemotherapy. NE has substantial morbidity and mortality, and its incidence has in...
-
Article
Open AccessPathological findings in the endometrium after microwave endometrial ablation
The acceptance of MEA in Japan is well demand due to its outstanding effectiveness and safety. Infrequently, a repeat MEA or hysterectomy is needed for recurrent menorrhagia in case of failure ablation. The re...
-
Article
Open AccessComparison between bidirectional Stratafix® barbed suture and conventional suture in laparoscopic myomectomy: a retrospective study
Laparoscopic myomectomy (LM) is one of the techniques feasible for the treatment of intramural myoma. This technique is reported to be difficult when large fibroids are involved because of excessive blood loss...
-
Article
Open AccessMucinous borderline ovarian tumors with BRAFV600E mutation may have low risk for progression to invasive carcinomas
Mucinous ovarian carcinomas (MOCs) are relatively rare. It has been proposed that a subset of mucinous cystadenomas (MCAs) may progress to mucinous borderline tumors (MBTs), and then to MOCs. KRAS is the predomin...
-
Article
Open AccessHigh PD-1 expression level is associated with an unfavorable prognosis in patients with cervical adenocarcinoma
The effectiveness of immunotherapy for cervical adenocarcinoma (CA) has not been demonstrated yet. Programmed cell death 1 (PD-1), programmed cell death-ligand 1 (PD-L1), and CD8 may be used as biomarkers of r...